ID   CDC42_MOUSE             Reviewed;         191 AA.
AC   P60766; A2A9U6; P21181; P25763; Q3THZ7; Q3TJK6; Q545V0; Q6P201; Q8BQ51;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   18-JUN-2025, entry version 207.
DE   RecName: Full=Cell division control protein 42 homolog {ECO:0000305};
DE            EC=3.6.5.2 {ECO:0000269|PubMed:24352656, ECO:0000269|PubMed:26969129};
DE   AltName: Full=G25K GTP-binding protein;
DE   Flags: Precursor;
GN   Name=Cdc42 {ECO:0000312|MGI:MGI:106211};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=8464478; DOI=10.1038/362462a0;
RA   Miki T., Smith C.L., Long J.E., Eva A., Fleming T.P.;
RT   "Oncogene ect2 is related to regulators of small GTP-binding proteins.";
RL   Nature 362:462-465(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=9224952; DOI=10.1016/s0167-4781(97)00027-4;
RA   Gong T.W., Shin J.J., Burmeister M., Lomax M.I.;
RT   "Complete cDNAs for CDC42 from chicken cochlea and mouse liver.";
RL   Biochim. Biophys. Acta 1352:282-292(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=8954774; DOI=10.1006/geno.1996.0586;
RA   Marks P.W., Kwiatkowski D.J.;
RT   "Genomic organization and chromosomal location of murine Cdc42.";
RL   Genomics 38:13-18(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=BALB/cJ, C57BL/6J, DBA/2J, and NOD;
RC   TISSUE=Amnion, Bone marrow, Heart, Kidney, Liver, Mammary gland,
RC   Placenta, Spinal ganglion, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Embryonic germ cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 108-120, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Hippocampus;
RA   Lubec G., Klug S.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   INTERACTION WITH CDC42EP4.
RX   PubMed=10490598; DOI=10.1128/mcb.19.10.6585;
RA   Joberty G., Perlungher R.R., Macara I.G.;
RT   "The Borgs, a new family of Cdc42 and TC10 GTPase-interacting proteins.";
RL   Mol. Cell. Biol. 19:6585-6597(1999).
RN   [9]
RP   SUBUNIT OF A COMPLEX CONTAINING PARD6B; PARD3 AND PRKCZ, AND MUTAGENESIS OF
RP   THR-17.
RX   PubMed=10934474; DOI=10.1038/35019573;
RA   Joberty G., Petersen C., Gao L., Macara I.G.;
RT   "The cell-polarity protein Par6 links Par3 and atypical protein kinase C to
RT   Cdc42.";
RL   Nat. Cell Biol. 2:531-539(2000).
RN   [10]
RP   INTERACTION WITH NET1.
RX   PubMed=9535835; DOI=10.1074/jbc.273.15.8616;
RA   Alberts A.S., Bouquin N., Johnston L.H., Treisman R.;
RT   "Analysis of RhoA-binding proteins reveals an interaction domain conserved
RT   in heterotrimeric G protein beta subunits and the yeast response regulator
RT   protein Skn7.";
RL   J. Biol. Chem. 273:8616-8622(1998).
RN   [11]
RP   INTERACTION WITH ARHGAP33/TCGAP.
RX   PubMed=12773384; DOI=10.1093/emboj/cdg262;
RA   Chiang S.-H., Hwang J., Legendre M., Zhang M., Kimura A., Saltiel A.R.;
RT   "TCGAP, a multidomain Rho GTPase-activating protein involved in insulin-
RT   stimulated glucose transport.";
RL   EMBO J. 22:2679-2691(2003).
RN   [12]
RP   ACTIVITY REGULATION, AND INTERACTION WITH DOCK11.
RX   PubMed=15710388; DOI=10.1016/j.febslet.2005.01.006;
RA   Nishikimi A., Meller N., Uekawa N., Isobe K., Schwartz M.A., Maruyama M.;
RT   "Zizimin2: a novel, DOCK180-related Cdc42 guanine nucleotide exchange
RT   factor expressed predominantly in lymphocytes.";
RL   FEBS Lett. 579:1039-1046(2005).
RN   [13]
RP   INTERACTION WITH DOCK11 AND IQGAP1, AND MUTAGENESIS OF THR-17 AND GLN-61.
RX   PubMed=16968698; DOI=10.1074/jbc.m606248200;
RA   Lin Q., Yang W., Baird D., Feng Q., Cerione R.A.;
RT   "Identification of a DOCK180-related guanine nucleotide exchange factor
RT   that is capable of mediating a positive feedback activation of Cdc42.";
RL   J. Biol. Chem. 281:35253-35262(2006).
RN   [14]
RP   INTERACTION WITH CCPG1.
RX   PubMed=17000758; DOI=10.1128/mcb.00670-06;
RA   Kostenko E.V., Olabisi O.O., Sahay S., Rodriguez P.L., Whitehead I.P.;
RT   "Ccpg1, a novel scaffold protein that regulates the activity of the Rho
RT   guanine nucleotide exchange factor Dbs.";
RL   Mol. Cell. Biol. 26:8964-8975(2006).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [16]
RP   ACTIVITY REGULATION, INTERACTION WITH DOCK8, AND SUBCELLULAR LOCATION.
RX   PubMed=22461490; DOI=10.1182/blood-2012-01-407098;
RA   Harada Y., Tanaka Y., Terasawa M., Pieczyk M., Habiro K., Katakai T.,
RA   Hanawa-Suetsugu K., Kukimoto-Niino M., Nishizaki T., Shirouzu M., Duan X.,
RA   Uruno T., Nishikimi A., Sanematsu F., Yokoyama S., Stein J.V., Kinashi T.,
RA   Fukui Y.;
RT   "DOCK8 is a Cdc42 activator critical for interstitial dendritic cell
RT   migration during immune responses.";
RL   Blood 119:4451-4461(2012).
RN   [17]
RP   FUNCTION, AND MUTAGENESIS OF GLY-12 AND THR-17.
RX   PubMed=22494997; DOI=10.1186/1742-4933-9-2;
RA   Sakabe I., Asai A., Iijima J., Maruyama M.;
RT   "Age-related guanine nucleotide exchange factor, mouse Zizimin2, induces
RT   filopodia in bone marrow-derived dendritic cells.";
RL   Immun. Ageing 9:2-2(2012).
RN   [18]
RP   CATALYTIC ACTIVITY, FUNCTION, ACTIVITY REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=24352656; DOI=10.1074/jbc.m113.534636;
RA   Raynaud F., Moutin E., Schmidt S., Dahl J., Bertaso F., Boeckers T.M.,
RA   Homburger V., Fagni L.;
RT   "Rho-GTPase-activating protein interacting with Cdc-42-interacting protein
RT   4 homolog 2 (Rich2): a new Ras-related C3 botulinum toxin substrate 1
RT   (Rac1) GTPase-activating protein that controls dendritic spine
RT   morphogenesis.";
RL   J. Biol. Chem. 289:2600-2609(2014).
RN   [19]
RP   FUNCTION.
RX   PubMed=25851601; DOI=10.1091/mbc.e14-08-1310;
RA   Jaudon F., Raynaud F., Wehrle R., Bellanger J.M., Doulazmi M., Vodjdani G.,
RA   Gasman S., Fagni L., Dusart I., Debant A., Schmidt S.;
RT   "The RhoGEF DOCK10 is essential for dendritic spine morphogenesis.";
RL   Mol. Biol. Cell 26:2112-2127(2015).
RN   [20]
RP   ACTIVITY REGULATION, AND CATALYTIC ACTIVITY.
RX   PubMed=26969129; DOI=10.1186/s13041-016-0206-6;
RA   Sarowar T., Grabrucker S., Foehr K., Mangus K., Eckert M., Bockmann J.,
RA   Boeckers T.M., Grabrucker A.M.;
RT   "Enlarged dendritic spines and pronounced neophobia in mice lacking the PSD
RT   protein RICH2.";
RL   Mol. Brain 9:28-28(2016).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MARCKS.
RX   PubMed=30185885; DOI=10.1038/s41598-018-31578-0;
RA   Brudvig J.J., Cain J.T., Sears R.M., Schmidt-Grimminger G.G.,
RA   Wittchen E.S., Adler K.B., Ghashghaei H.T., Weimer J.M.;
RT   "MARCKS regulates neuritogenesis and interacts with a CDC42 signaling
RT   network.";
RL   Sci. Rep. 8:13278-13278(2018).
CC   -!- FUNCTION: Plasma membrane-associated small GTPase which cycles between
CC       an active GTP-bound and an inactive GDP-bound state (PubMed:24352656).
CC       In its active state binds to a variety of effector proteins to regulate
CC       cellular responses. Involved in epithelial cell polarization processes.
CC       Regulates the bipolar attachment of spindle microtubules to
CC       kinetochores before chromosome congression in metaphase. Regulates cell
CC       migration (By similarity). In neurons, plays a role in the extension
CC       and maintenance of the formation of filopodia, thin and actin-rich
CC       surface projections. Required for DOCK10-mediated spine formation in
CC       Purkinje cells and hippocampal neurons (PubMed:25851601). Facilitates
CC       filopodia formation upon DOCK11-activation (PubMed:22494997). Upon
CC       activation by CaMKII, modulates dendritic spine structural plasticity
CC       by relaying CaMKII transient activation to synapse-specific, long-term
CC       signaling (By similarity). Also plays a role in phagocytosis through
CC       organization of the F-actin cytoskeleton associated with forming
CC       phagocytic cups (By similarity). Upon activation by PLEKHG4B, involved
CC       in actin cytoskeletal remodeling during epithelial cell-cell junction
CC       formation (By similarity). {ECO:0000250|UniProtKB:P60953,
CC       ECO:0000250|UniProtKB:Q8CFN2, ECO:0000269|PubMed:22494997,
CC       ECO:0000269|PubMed:24352656, ECO:0000269|PubMed:25851601}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.2;
CC         Evidence={ECO:0000269|PubMed:24352656, ECO:0000269|PubMed:26969129};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670;
CC         Evidence={ECO:0000305|PubMed:24352656, ECO:0000305|PubMed:26969129};
CC   -!- ACTIVITY REGULATION: Regulated by guanine nucleotide exchange factors
CC       (GEFs) which promote the exchange of bound GDP for free GTP, GTPase
CC       activating proteins (GAPs) which increase the GTP hydrolysis activity,
CC       and GDP dissociation inhibitors which inhibit the dissociation of the
CC       nucleotide from the GTPase. Inhibited by GAPs such as ARHGAP44
CC       (PubMed:24352656, PubMed:26969129). {ECO:0000269|PubMed:15710388,
CC       ECO:0000269|PubMed:22461490, ECO:0000269|PubMed:24352656,
CC       ECO:0000269|PubMed:26969129}.
CC   -!- SUBUNIT: Interacts with CDC42EP1, CDC42EP2, CDC42EP3, CDC42EP4,
CC       CDC42EP5, CDC42SE1, CDC42SE2, PARD6A, PARD6B and PARD6G (in a GTP-
CC       dependent manner) (PubMed:10490598, PubMed:10934474). Interacts with
CC       activated CSPG4 and with BAIAP2 (By similarity). Interacts with
CC       DOCK11/Zizimin2; the interaction activates CDC42 by exchanging GDP for
CC       GTP (PubMed:15710388, PubMed:16968698). Interacts with DOCK9; the
CC       interaction activates CDC42 by exchanging GDP for GTP (By similarity).
CC       Interacts with DOCK8 (via DHR-2 domain); the interaction activates
CC       CDC42 by exchanging GDP for GTP (PubMed:22461490). Interacts with
CC       IQGAP1 (PubMed:16968698). Interacts with NET1 and ARHGAP33/TCGAP
CC       (PubMed:12773384, PubMed:9535835). Part of a complex with PARD3, PARD6A
CC       or PARD6B and PRKCI or PRKCZ (PubMed:10934474). The GTP-bound form
CC       interacts with CCPG1 (PubMed:17000758). Interacts with USP6 (By
CC       similarity). Interacts with NEK6 (By similarity). Part of a collagen
CC       stimulated complex involved in cell migration composed of CDC42, CRK,
CC       TNK2 and BCAR1/p130cas (By similarity). Interacts with ITGB1BP1 (By
CC       similarity). Interacts with ARHGDIA; this interaction inactivates and
CC       stabilizes CDC42. Interacts with ARHGDIB; this maintains CDC42 in the
CC       inactive, GDP-bound form (By similarity). Interacts in (GTP-bound form)
CC       with FNBP1L and ABI1, but only in the presence of FNBP1L (By
CC       similarity). Interacts with MARCKS (PubMed:30185885). Interacts with
CC       CD151 and ITGB1 (By similarity). {ECO:0000250|UniProtKB:P60953,
CC       ECO:0000269|PubMed:10490598, ECO:0000269|PubMed:10934474,
CC       ECO:0000269|PubMed:12773384, ECO:0000269|PubMed:15710388,
CC       ECO:0000269|PubMed:16968698, ECO:0000269|PubMed:17000758,
CC       ECO:0000269|PubMed:22461490, ECO:0000269|PubMed:9535835}.
CC   -!- INTERACTION:
CC       P60766; O88643: Pak1; NbExp=2; IntAct=EBI-81763, EBI-457240;
CC       P60766; P63044: Vamp2; NbExp=2; IntAct=EBI-81763, EBI-521920;
CC       P60766; Q13153: PAK1; Xeno; NbExp=3; IntAct=EBI-81763, EBI-1307;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22461490,
CC       ECO:0000269|PubMed:30185885}; Lipid-anchor {ECO:0000305}; Cytoplasmic
CC       side {ECO:0000305}. Midbody {ECO:0000250|UniProtKB:P60953}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000250|UniProtKB:P60953}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:P60953}. Cytoplasm
CC       {ECO:0000269|PubMed:22461490}. Cell projection, lamellipodium membrane
CC       {ECO:0000269|PubMed:22461490}; Peripheral membrane protein
CC       {ECO:0000305|PubMed:22461490}; Cytoplasmic side
CC       {ECO:0000305|PubMed:22461490}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:24352656}. Note=Localizes to spindle during
CC       prometaphase cells (By similarity). Moves to the central spindle as
CC       cells progressed through anaphase to telophase. Localizes at the end of
CC       cytokinesis in the intercellular bridge formed between two daughter
CC       cells (By similarity). Its localization is regulated by the activities
CC       of guanine nucleotide exchange factor ECT2 and GTPase activating
CC       protein RACGAP1. Colocalizes with NEK6 in the centrosome (By
CC       similarity). In its active GTP-bound form localizes to the leading edge
CC       membrane of migrating dendritic cells (PubMed:22461490).
CC       {ECO:0000250|UniProtKB:P60953, ECO:0000269|PubMed:22461490}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2; Synonyms=Placental;
CC         IsoId=P60766-2, P21181-4; Sequence=Displayed;
CC       Name=1; Synonyms=Brain;
CC         IsoId=P60766-1, P21181-1; Sequence=VSP_040585, VSP_040586;
CC   -!- PTM: Phosphorylated by SRC in an EGF-dependent manner, this stimulates
CC       the binding of the Rho-GDP dissociation inhibitor RhoGDI.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Rho family. CDC42
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L11318; AAA37410.1; -; mRNA.
DR   EMBL; U37720; AAC00028.1; -; mRNA.
DR   EMBL; L78075; AAB40051.1; -; Genomic_DNA.
DR   EMBL; AK003098; BAB22563.1; -; mRNA.
DR   EMBL; AK051543; BAC34669.1; -; mRNA.
DR   EMBL; AK075567; BAC35825.1; -; mRNA.
DR   EMBL; AK144216; BAE25778.1; -; mRNA.
DR   EMBL; AK151087; BAE30100.1; -; mRNA.
DR   EMBL; AK151726; BAE30644.1; -; mRNA.
DR   EMBL; AK153564; BAE32098.1; -; mRNA.
DR   EMBL; AK154870; BAE32891.1; -; mRNA.
DR   EMBL; AK159470; BAE35111.1; -; mRNA.
DR   EMBL; AK166281; BAE38678.1; -; mRNA.
DR   EMBL; AK167195; BAE39325.1; -; mRNA.
DR   EMBL; AK167400; BAE39489.1; -; mRNA.
DR   EMBL; AK167609; BAE39663.1; -; mRNA.
DR   EMBL; AK168013; BAE40000.1; -; mRNA.
DR   EMBL; AK168076; BAE40049.1; -; mRNA.
DR   EMBL; AK168089; BAE40062.1; -; mRNA.
DR   EMBL; AK168276; BAE40222.1; -; mRNA.
DR   EMBL; AK168758; BAE40595.1; -; mRNA.
DR   EMBL; AK168820; BAE40647.1; -; mRNA.
DR   EMBL; AK169122; BAE40902.1; -; mRNA.
DR   EMBL; AK169232; BAE41001.1; -; mRNA.
DR   EMBL; AK169805; BAE41379.1; -; mRNA.
DR   EMBL; AL645468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC064792; AAH64792.1; -; mRNA.
DR   CCDS; CCDS18816.1; -.
DR   CCDS; CCDS57305.1; -. [P60766-1]
DR   RefSeq; NP_001230698.1; NM_001243769.2. [P60766-1]
DR   RefSeq; NP_001407060.1; NM_001420131.1. [P60766-2]
DR   RefSeq; NP_001407061.1; NM_001420132.1. [P60766-2]
DR   RefSeq; NP_001407062.1; NM_001420133.1. [P60766-2]
DR   RefSeq; NP_001407063.1; NM_001420134.1. [P60766-1]
DR   RefSeq; NP_001407064.1; NM_001420135.1. [P60766-1]
DR   RefSeq; NP_001407065.1; NM_001420136.1. [P60766-1]
DR   RefSeq; NP_033991.1; NM_009861.4. [P60766-2]
DR   RefSeq; XP_030108999.1; XM_030253139.2. [P60766-2]
DR   RefSeq; XP_030109001.1; XM_030253141.2. [P60766-1]
DR   RefSeq; XP_036019511.1; XM_036163618.1. [P60766-2]
DR   RefSeq; XP_036019512.1; XM_036163619.1. [P60766-1]
DR   PDB; 3EG5; X-ray; 2.70 A; A/C=1-178.
DR   PDB; 5C2J; X-ray; 2.50 A; B=1-191.
DR   PDBsum; 3EG5; -.
DR   PDBsum; 5C2J; -.
DR   AlphaFoldDB; P60766; -.
DR   BMRB; P60766; -.
DR   SMR; P60766; -.
DR   BioGRID; 198627; 72.
DR   CORUM; P60766; -.
DR   DIP; DIP-32554N; -.
DR   FunCoup; P60766; 3827.
DR   IntAct; P60766; 15.
DR   MINT; P60766; -.
DR   STRING; 10090.ENSMUSP00000054634; -.
DR   ChEMBL; CHEMBL4523257; -.
DR   GlyGen; P60766; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P60766; -.
DR   PhosphoSitePlus; P60766; -.
DR   SwissPalm; P60766; -.
DR   jPOST; P60766; -.
DR   PaxDb; 10090-ENSMUSP00000054634; -.
DR   PeptideAtlas; P60766; -.
DR   ProteomicsDB; 280033; -.
DR   ProteomicsDB; 280034; -. [P60766-1]
DR   Pumba; P60766; -.
DR   Antibodypedia; 3818; 526 antibodies from 43 providers.
DR   DNASU; 12540; -.
DR   Ensembl; ENSMUST00000030417.10; ENSMUSP00000030417.10; ENSMUSG00000006699.18. [P60766-1]
DR   Ensembl; ENSMUST00000051477.13; ENSMUSP00000054634.7; ENSMUSG00000006699.18. [P60766-2]
DR   GeneID; 12540; -.
DR   KEGG; mmu:12540; -.
DR   UCSC; uc008viw.3; mouse.
DR   UCSC; uc008viy.2; mouse. [P60766-1]
DR   AGR; MGI:106211; -.
DR   CTD; 998; -.
DR   MGI; MGI:106211; Cdc42.
DR   VEuPathDB; HostDB:ENSMUSG00000006699; -.
DR   eggNOG; KOG0393; Eukaryota.
DR   GeneTree; ENSGT00940000153675; -.
DR   HOGENOM; CLU_041217_21_3_1; -.
DR   InParanoid; P60766; -.
DR   OMA; GDEPYTF; -.
DR   OrthoDB; 8830751at2759; -.
DR   PhylomeDB; P60766; -.
DR   Reactome; R-MMU-114604; GPVI-mediated activation cascade.
DR   Reactome; R-MMU-182971; EGFR downregulation.
DR   Reactome; R-MMU-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-MMU-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-MMU-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-MMU-418885; DCC mediated attractive signaling.
DR   Reactome; R-MMU-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-MMU-525793; Myogenesis.
DR   Reactome; R-MMU-5625970; RHO GTPases activate KTN1.
DR   Reactome; R-MMU-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-MMU-5627123; RHO GTPases activate PAKs.
DR   Reactome; R-MMU-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-MMU-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-MMU-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-MMU-8964616; G beta:gamma signalling through CDC42.
DR   Reactome; R-MMU-9013148; CDC42 GTPase cycle.
DR   Reactome; R-MMU-9013149; RAC1 GTPase cycle.
DR   Reactome; R-MMU-9013404; RAC2 GTPase cycle.
DR   Reactome; R-MMU-9013406; RHOQ GTPase cycle.
DR   Reactome; R-MMU-9013408; RHOG GTPase cycle.
DR   Reactome; R-MMU-9013420; RHOU GTPase cycle.
DR   Reactome; R-MMU-9013423; RAC3 GTPase cycle.
DR   Reactome; R-MMU-9013424; RHOV GTPase cycle.
DR   Reactome; R-MMU-983231; Factors involved in megakaryocyte development and platelet production.
DR   BioGRID-ORCS; 12540; 27 hits in 78 CRISPR screens.
DR   CD-CODE; 01CA17F3; Centrosome.
DR   CD-CODE; CE726F99; Postsynaptic density.
DR   ChiTaRS; Cdc42; mouse.
DR   EvolutionaryTrace; P60766; -.
DR   PRO; PR:P60766; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; P60766; protein.
DR   Bgee; ENSMUSG00000006699; Expressed in peripheral lymph node and 272 other cell types or tissues.
DR   GO; GO:0045177; C:apical part of cell; IDA:MGI.
DR   GO; GO:0031252; C:cell leading edge; IDA:MGI.
DR   GO; GO:0071944; C:cell periphery; IDA:MGI.
DR   GO; GO:0042995; C:cell projection; IDA:MGI.
DR   GO; GO:0005911; C:cell-cell junction; IDA:MGI.
DR   GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0030175; C:filopodium; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0017119; C:Golgi transport complex; IEA:Ensembl.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031256; C:leading edge membrane; IDA:MGI.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; ISS:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0051233; C:spindle midzone; ISS:UniProtKB.
DR   GO; GO:0000322; C:storage vacuole; IDA:MGI.
DR   GO; GO:0034191; F:apolipoprotein A-I receptor binding; IEA:Ensembl.
DR   GO; GO:0003925; F:G protein activity; IEA:UniProtKB-EC.
DR   GO; GO:0032427; F:GBD domain binding; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; ISO:MGI.
DR   GO; GO:0030742; F:GTP-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0051022; F:Rho GDP-dissociation inhibitor binding; IDA:MGI.
DR   GO; GO:0031996; F:thioesterase binding; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0007015; P:actin filament organization; ISS:UniProtKB.
DR   GO; GO:0034332; P:adherens junction organization; IMP:MGI.
DR   GO; GO:0003161; P:cardiac conduction system development; IGI:MGI.
DR   GO; GO:0003253; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; IMP:MGI.
DR   GO; GO:0034329; P:cell junction assembly; ISS:UniProtKB.
DR   GO; GO:0098609; P:cell-cell adhesion; TAS:UniProtKB.
DR   GO; GO:0071346; P:cellular response to type II interferon; IDA:MGI.
DR   GO; GO:0036336; P:dendritic cell migration; IGI:MGI.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; IMP:UniProtKB.
DR   GO; GO:0035050; P:embryonic heart tube development; IMP:MGI.
DR   GO; GO:0006897; P:endocytosis; IMP:MGI.
DR   GO; GO:0016197; P:endosomal transport; TAS:UniProtKB.
DR   GO; GO:0086101; P:endothelin receptor signaling pathway involved in heart process; IMP:MGI.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; ISS:UniProtKB.
DR   GO; GO:0051649; P:establishment of localization in cell; IMP:MGI.
DR   GO; GO:0035088; P:establishment or maintenance of apical/basal cell polarity; IMP:MGI.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; TAS:UniProtKB.
DR   GO; GO:0046847; P:filopodium assembly; IDA:MGI.
DR   GO; GO:0060047; P:heart contraction; IGI:MGI.
DR   GO; GO:0003015; P:heart process; IMP:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0044788; P:modulation by host of viral process; IEA:Ensembl.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; IEA:Ensembl.
DR   GO; GO:0048664; P:neuron fate determination; IMP:MGI.
DR   GO; GO:0038189; P:neuropilin signaling pathway; IEA:Ensembl.
DR   GO; GO:0007097; P:nuclear migration; IMP:MGI.
DR   GO; GO:0051647; P:nucleus localization; IMP:MGI.
DR   GO; GO:0006911; P:phagocytosis, engulfment; ISS:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0060501; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; IMP:CACAO.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IMP:UniProtKB.
DR   GO; GO:0010592; P:positive regulation of lamellipodium assembly; IEA:Ensembl.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:MGI.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:MGI.
DR   GO; GO:0048549; P:positive regulation of pinocytosis; IMP:UniProtKB.
DR   GO; GO:0031274; P:positive regulation of pseudopodium assembly; IEA:Ensembl.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0008104; P:protein localization; IMP:MGI.
DR   GO; GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; ISS:UniProtKB.
DR   GO; GO:0051489; P:regulation of filopodium assembly; ISS:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:MGI.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:0007266; P:Rho protein signal transduction; TAS:MGI.
DR   CDD; cd01874; Cdc42; 1.
DR   FunFam; 3.40.50.300:FF:000167; Cell division control protein 42 homolog; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR037874; Cdc42.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd.
DR   InterPro; IPR001806; Small_GTPase.
DR   InterPro; IPR003578; Small_GTPase_Rho.
DR   NCBIfam; TIGR00231; small_GTP; 1.
DR   PANTHER; PTHR24072; RHO FAMILY GTPASE; 1.
DR   Pfam; PF00071; Ras; 1.
DR   PRINTS; PR00449; RASTRNSFRMNG.
DR   SMART; SM00175; RAB; 1.
DR   SMART; SM00173; RAS; 1.
DR   SMART; SM00174; RHO; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51420; RHO; 1.
DR   TreeFam; TF101109; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Cytoplasm; Cytoskeleton; Differentiation; Direct protein sequencing;
KW   GTP-binding; Hydrolase; Lipoprotein; Membrane; Methylation; Neurogenesis;
KW   Nucleotide-binding; Phosphoprotein; Prenylation; Reference proteome.
FT   CHAIN           1..188
FT                   /note="Cell division control protein 42 homolog"
FT                   /id="PRO_0000030427"
FT   PROPEP          189..191
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000030428"
FT   MOTIF           32..40
FT                   /note="Effector region"
FT                   /evidence="ECO:0000255"
FT   BINDING         10..17
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         57..61
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         115..118
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         64
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000250|UniProtKB:P60953"
FT   MOD_RES         188
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000250"
FT   LIPID           188
FT                   /note="S-geranylgeranyl cysteine"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         163
FT                   /note="K -> R (in isoform 1)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_040585"
FT   VAR_SEQ         182..191
FT                   /note="PKKSRRCVLL -> TQPKRKCCIF (in isoform 1)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_040586"
FT   MUTAGEN         12
FT                   /note="G->V: No effect on filopodia formation."
FT                   /evidence="ECO:0000269|PubMed:22494997"
FT   MUTAGEN         17
FT                   /note="T->N: Constitutively inactivated. Abolishes
FT                   interaction with PARD6 and DOCK11. Inhibits filopodia
FT                   formation."
FT                   /evidence="ECO:0000269|PubMed:10934474,
FT                   ECO:0000269|PubMed:16968698, ECO:0000269|PubMed:22494997"
FT   MUTAGEN         61
FT                   /note="Q->L: Constitutively activated. Enhances interaction
FT                   with DOCK11."
FT                   /evidence="ECO:0000269|PubMed:16968698"
FT   CONFLICT        26
FT                   /note="N -> D (in Ref. 4; BAC34669)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        66
FT                   /note="R -> G (in Ref. 6; AAH64792)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        85
FT                   /note="V -> I (in Ref. 4; BAE39489)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        116
FT                   /note="Q -> K (in Ref. 4; BAE40049)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        171
FT                   /note="E -> G (in Ref. 6; AAH64792)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..9
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           16..25
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   STRAND          36..46
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   STRAND          49..58
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           62..64
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   TURN            65..67
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           68..71
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   STRAND          76..83
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           87..95
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           97..104
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   STRAND          110..115
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           117..121
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           123..131
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           139..148
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   TURN            159..161
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           165..177
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   STRAND          178..181
FT                   /evidence="ECO:0007829|PDB:5C2J"
FT   HELIX           183..186
FT                   /evidence="ECO:0007829|PDB:5C2J"
SQ   SEQUENCE   191 AA;  21259 MW;  51A437E22A4D8FFF CRC64;
     MQTIKCVVVG DGAVGKTCLL ISYTTNKFPS EYVPTVFDNY AVTVMIGGEP YTLGLFDTAG
     QEDYDRLRPL SYPQTDVFLV CFSVVSPSSF ENVKEKWVPE ITHHCPKTPF LLVGTQIDLR
     DDPSTIEKLA KNKQKPITPE TAEKLARDLK AVKYVECSAL TQKGLKNVFD EAILAALEPP
     EPKKSRRCVL L
//
